News for Alector, Inc. (ALEC)

**media[544998]**

Continue to advance preclinical and research pipeline, including key programs selectively combined with Alector Brain Carrier, enhancing the company's commitmen

Alector (ALEC) said AbbVie (ABBV) has sent written notice that it is terminating the TREM2 program, the last remaining program under their development agreement. Read more here.

Alector, Inc. (ALEC) experienced a significant stock movement, dropping 5.21% to $1.82 per share. The trading volume reached 324,402 shares with a turnover rate

Alector stock hits 52-week low at $1.73 amid market challenges

Alector, Inc. (ALEC) saw a significant stock price drop of 5.15%, currently trading at $1.94 per share. The trading volume reached 477,885 shares, with a turnov

On November 29, 2024, RA Capital Management, L.P. made a strategic move by acquiring 9,695,228 shares of Alector Inc (ALEC) at a transaction price of $2.59 per

Alector, Inc. (ALEC), a clinical-stage biopharmaceutical company, experienced a significant stock decline of 5.02%. The stock is currently priced at $2.46 per s

Alector has significant cash reserves but faces high cash burn, with no immediate catalysts and uncertain prospects for its remaining pipeline. Learn more on ALEC stock here.

U.S. stocks higher at close of trade; Dow Jones Industrial Average up 0.28%

U.S. stocks traded mostly higher toward the end of trading, with the S&P 500 gaining around 0.5% on Tuesday. The Dow traded up 0.05% to 44,759.66 while the NAS...

Published Nov 26, 2024 02:02PM ET © Reuters. Eli Lilly (NYSE: ), Amazon lead Tuesday's market cap stock movers Article Content: Tuesday's trading session i...

U.S. stocks traded mixed midway through trading, with the Nasdaq Composite gaining around 100 points on Tuesday. The Dow traded down 0.26% to 44,621.76 while t...

U.S. stock futures were slightly higher this morning, with the Nasdaq futures gaining around 0.1% on Tuesday. Shares of Leslie’s, Inc. LESL fell sharply in t...

California-based Poseida Therapeutics, Inc., (PSTX), a clinical-stage biopharmaceutical company is up over 226 percent in Tuesday's pre-market trading. The following are some of the other stocks making big moves in Tuesday's pre-market trading.

Alector secures $50 million credit facility from Hercules Capital

The rising incidence of Alzheimer's and other tau-related disorders, driven by an aging global population, is significantly boosting the demand for...

The growing demand for corporate wellness is largely driven by factors such as increased screen time, higher workloads, rapid urbanization, poor diet,...

The next-generation complement therapeutics market is experiencing positive growth driven by the rising global incidence of cardiovascular, genetic,...